Error: Could not add to watchlist. X

Lacuna Sicav - Adamant Asia Pacific Health

+ Watchlist
LACUAPH:LX
216.54
EUR
4.29
1.94%
As of 00:59:30 ET on 06/30/2015.
Volume
0
Previous Close
220.83
52Wk Range
149.43 - 227.84
1 Yr Return
44.17%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/30/2015)
216.54
Total Assets (m EUR) (on 06/30/2015)
120.204
Inception Date
03/30/2006
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
OLIVER KUBLI
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.09%
Expense Ratio
2.76%
Top Fund Holdings
Name Position Value % of Fund
Celltrion Inc 165.17 k 4.78 m 4.09
Medy-Tox Inc 20.00 k 4.56 m 3.90
Glenmark Pharmaceuticals Ltd 443.00 k 4.48 m 3.83
Sawai Pharmaceutical Co Ltd 90.00 k 4.29 m 3.67
Shanghai Fosun Pharmaceutical 1.50 m 4.26 m 3.64
Lupin Ltd 218.00 k 4.03 m 3.45
Osstem Implant Co Ltd 150.00 k 3.86 m 3.30
M3 Inc 270.00 k 3.75 m 3.21
CSPC Pharmaceutical Group Ltd 5.30 m 3.58 m 3.06
Shimadzu Corp 400.00 k 3.45 m 2.95
Profile
Lacuna Sicav-Adamant Asia Pacific Health is an open-end fund incorporated in Luxembourg. The Fund's objective is growth. The Fund invests at least two-thirds in equities and equity-like securities of companies from the Pacific Rim in the healthcare sector.
ADDRESS
Hauck & Aufhauser Investment Gesells
1c, rue Gabriel Lippmann
L - 5365 Munsbach
Luxembourg
PHONE
+352 45 13 14 500
WEBSITE
-